Solute carrier family 2 member 1 messenger RNA (SLC2A1 mRNA) (SLC2A1 mRNA)

Solute carrier family 2 member 1 messenger RNA (SLC2A1 mRNA) is the transcript that encodes the Glucose transporter type 1 (GLUT1) protein, which is the primary mediator of basal glucose uptake in most human tissues (UniProt P11166). This mRNA is particularly vital for the transport of glucose across the blood-brain barrier and into erythrocytes, ensuring a steady supply of energy to the central nervous system (NCBI Gene: 6513). In many malignancies, SLC2A1 mRNA is significantly upregulated in response to oncogenic signaling and hypoxia, facilitating the Warburg effect where cancer cells rely on high rates of glycolysis for proliferation (PubMed: 25613372). Therapeutic targeting of this mRNA using technologies like small interfering RNA (siRNA) or antisense oligonucleotides (ASOs) aims to reduce GLUT1 protein levels, thereby starving tumor cells of glucose (PubMed: 22430211). Conversely, mutations that reduce the expression or stability of SLC2A1 mRNA lead to GLUT1 deficiency syndrome, a severe neurological condition characterized by seizures and motor impairment (PubMed: 30154015).

Other names

GLUT1 mRNAGlucose transporter type 1 mRNAGLUT1 transcriptHepG2 glucose transporter mRNA

RNA interference (RNAi) via siRNA-mediated cleavage, antisense-mediated degradation by RNase H, inhibition of translation by steric hindrance, and modulation of mRNA stability through targeting RNA-binding proteins like HuR (PubMed: 25613372, 25858214).